Literature DB >> 26515333

Does the elevation of serum carbohydrate antigen 19-9 level predict poor overall survival in patients with hepatocellular carcinoma?

Yan-Yan Wang1, Jian-Hong Zhong1, Zhan Lu1, Hong-Gui Qin1, Le-Qun Li2.   

Abstract

Entities:  

Keywords:  Carbohydrate antigen 19-9; Hepatocellular carcinoma; Overall survival

Mesh：

Substances：

Year:  2015        PMID： 26515333     DOI： 10.1007/s13277-015-4326-x

Source DB:  PubMed          Journal:  Tumour Biol        ISSN： 1010-4283


× No keyword cloud information.
  8 in total

Review 1.  Hepatocellular carcinoma.

Authors:  Hashem B El-Serag
Journal:  N Engl J Med       Date:  2011-09-22       Impact factor: 91.245

2.  Serum carbohydrate antigen 19-9 and prognosis of patients with gastric cancer.

Authors:  Jiuchang Xiao; Xiaoyan He; Zengyan Wang; Jiying Hu; Fang Sun; Feng Qi; Shugang Yang; Zhenyu Xiao
Journal:  Tumour Biol       Date:  2014-02

3.  Elevated perioperative serum CA 19-9 levels are independent predictors of poor survival in patients with resectable cholangiocarcinoma.

Authors:  Naru Kondo; Yoshiaki Murakami; Kenichiro Uemura; Takeshi Sudo; Yasushi Hashimoto; Hayato Sasaki; Taijiro Sueda
Journal:  J Surg Oncol       Date:  2014-06-02       Impact factor: 3.454

4.  Prognostic role of serum carbohydrate antigen 19-9 levels in patients with resectable hepatocellular carcinoma.

Authors:  Jinyan Zhang; Tao Huang; Fan Zhang; Junming Xu; Guoqing Chen; Xiaoliang Wang; Li Huang; Zhihai Peng
Journal:  Tumour Biol       Date:  2015-03-19

5.  Preoperative prediction of survival in resectable gallbladder cancer by a combined utilization of CA 19-9 and carcinoembryonic antigen.

Authors:  Tunan Yu; Hong Yu; Xiujun Cai
Journal:  Chin Med J (Engl)       Date:  2014       Impact factor: 2.628

Review 6.  Tumor markers in pancreatic cancer: a European Group on Tumor Markers (EGTM) status report.

Authors:  M J Duffy; C Sturgeon; R Lamerz; C Haglund; V L Holubec; R Klapdor; A Nicolini; O Topolcan; V Heinemann
Journal:  Ann Oncol       Date:  2009-08-18       Impact factor: 32.976

7.  Significance of serum tumor markers carcinoembryonic antigen, CA 19-9, CA 125, and CA 15-3 in pre-orthotopic liver transplantation evaluation.

Authors:  A Pissaia; D Bernard; O Scatton; O Soubrane; F Conti; Y Calmus
Journal:  Transplant Proc       Date:  2009-03       Impact factor: 1.066

8.  Management of hepatocellular carcinoma: an update.

Authors:  Jordi Bruix; Morris Sherman
Journal:  Hepatology       Date:  2011-03       Impact factor: 17.425
  8 in total
  2 in total

1.  Is CA 19-9 of Any Help in the Management of Cholangiocarcinoma?

Authors:  Marília Cravo
Journal:  GE Port J Gastroenterol       Date:  2017-03-23

2.  Clinical value of preoperative serum CA 19-9 and CA 125 levels in predicting the resectability of hilar cholangiocarcinoma.

Authors:  Hai-Jie Hu; Hui Mao; Yong-Qiong Tan; Anuj Shrestha; Wen-Jie Ma; Qin Yang; Jun-Ke Wang; Nan-Sheng Cheng; Fu-Yu Li
Journal:  Springerplus       Date:  2016-04-30
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.